• English
  • Français
  • Español
  • Facebook
  • RSS
  • Twitter

Therapeutics Initiative

Independent Healthcare Evidence

  • TI
  • About Us
    • Oversight Committee
    • Steering Committee
    • Working Groups
      • Drug Assessment
      • Education
      • PharmacoEpidemiology
      • Cochrane Hypertension
    • Members
    • TI Surveys
    • Questions & Answers
  • Therapeutics Letter
  • Our Evidence Reviews
  • Portrait
  • Continuing Education
  • Contact Us
  • Subscribe
Home > Education > [Feb 24] TI Methods Speaker Series: Should research in predatory journals be included in systematic reviews?

[Feb 24] TI Methods Speaker Series: Should research in predatory journals be included in systematic reviews?

February 1, 2021 Education Leave a Comment

Share
Dr. Larissa Shamseer
Dr. Larissa Shamseer

TI Methods Speaker Series

The TI Methods Speaker Series are offered free of charge and everyone is welcome. The event is held at noon on the last Wednesday of each month and used to take place in Rudy North Lecture Theatre (CBH 101) in the Centre for Brain Health, UBC Point Grey Campus. During the COVID-19 pandemic, while physical distancing measures are in effect, the TI Methods Speaker Series are offered via videoconference. The presentations are recorded and the video recordings are posted online. 


This event has already taken place. A video recording will be posted here soon.


WHEN: Wednesday, February 24th, 2021 from 12:00 to 1:00 PM PDT [click here to convert to your local time]

WHERE: Offered online using Zoom.

TITLE: Should research in predatory journals be included in systematic reviews?

SPEAKER: Dr. Larissa Shamseer, Postdoctoral Research Fellow, Knowledge Translation Program of the Li Ka Shing Knowledge Institute, Toronto, ON.


About the topic: So-called “predatory” journals have become pervasive in scholarly publishing and their increasing presence has signaled alarm bells among the scientific and publishing communities. Predatory journals and their content are considered untrustworthy due to their failure (and sometimes false claims) to peer review. We ought to be concerned, however, that some journals once-labelled as “predatory” may not intentionally carry out nefarious or deceptive operations, and that potentially useful research may be contained in such journals. This talk considers the origins and definitions of the term “predatory” journal, as well as how systematic reviewers ought to approach predatory journals/research published in predatory journals.

About the speaker: Dr. Larissa Shamseer (MSc, PhD) is a post-doctoral research fellow with the Knowledge Translation Program of the Li Ka Shing Knowledge Institute. She completed her PhD in Epidemiology with the School of Epidemiology and Public Health at the University of Ottawa. She is a methodologist specializing in both knowledge synthesis and publication science. Her research to date has focused on optimizing research transparency to reduce research waste. She has over 70 publications in these areas, including several first author publications in high-impact journals (e.g. Nature, BMJ). Dr. Shamseer led the development of the widely-used Preferred Reporting Items for Systematic review and Meta-Analysis Protocols (PRISMA-P 2015) guideline (cited over 9000 times, Scopus), and was on the steering committee updating the PRISMA Statement (2021). She also led early, extensive research characterizing “predatory” publishing during her PhD. Dr. Shamseer is currently undertaking research examining equity in academic publishing.

About the TI Methods Speaker Series: The TI Methods Speaker Series are offered free of charge and everyone is welcome. The event is held at noon on the last Wednesday of each month. During the COVID-19 pandemic, while physical distancing measures are in effect, the TI Methods Speaker Series are offered via videoconference. The presentations are recorded and the video recordings are posted online. Click here to view the scheduled topics for 2021 and click here to view a list of TI Methods Speaker Series talks offered in 2020.

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

 

  • About Us
    • Oversight Committee
    • Questions & Answers
    • Steering Committee
    • Working Groups
      • Drug Assessment
      • Education
      • PharmacoEpidemiology
      • Cochrane Hypertension
    • Members
    • TI Surveys
  • Portrait
    • Frequently Asked Questions
    • Portrait Contact
  • Therapeutics Letter
  • Our Evidence Reviews
  • Get Involved
  • Continuing Education
    • Best Evidence
  • Contact Us
  • Terms & Policies
    • Legal Information & Terms of Use
    • Privacy Policy
    • Acceptable Use Policy

Categories

  • News (123)
  • Therapeutics Letter (133)
  • Portrait (1)
  • Drug Assessments (39)
  • PharmacoEpidemiology (75)
  • Podcasts & Videos (52)

Recent Seminars

[Mar 10] Therapeutics Initiative Virtual Workshop – Using Evidence in Shared Decision Making: A Case-based, Critical Appraisal Approach for Busy Clinicians

Register
Share

[Mar 17] Therapeutics Initiative Best Evidence Webinar: Withdrawal of antihypertensive drugs in older people

Register
Share

[Mar 31] TI Methods Speaker Series: The development of a risk of bias tool for network meta-analysis

Register
Share

Therapeutics Initiative

Our mission is to provide physicians, nurse practitioners, pharmacists, allied health professionals, and the public with up-to-date, independent, evidence-based, practical information on healthcare interventions. Read more Donate

Contact

2176 Health Sciences Mall
Vancouver, BC, Canada V6T 1Z3
Contact us
Office: +1 604-822-0700
Fax: +1 604-822-0701

UBC logoISDB logo

Subscribe

Subscribe to receive email notifications from the TI about the Therapeutics Letter, upcoming educational events, personal prescribing portraits and other news and recent publications. SUBSCRIBE

© 1994 - 2021 Therapeutics Initiative · Terms & Policies · TM